The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Drug Delivery Systems-Global Market Insights and Sales Trends 2024

Drug Delivery Systems-Global Market Insights and Sales Trends 2024

Publishing Date : Dec, 2023

License Type :
 

Report Code : 1860247

No of Pages : 103

Ask Your Query

Synopsis
Drug Delivery includes formulations, technologies, methods, and systems for transferring an active pharmaceutical ingredients into the body to safely provide therapeutic effect.

The global Drug Delivery Systems market size is expected to reach US$ 673940 million by 2029, growing at a CAGR of 3.9% from 2023 to 2029. The market is mainly driven by the significant applications of Drug Delivery Systems in various end use industries. The expanding demands from the Cardiovascular Diseases, Oncology, Urology and Diabetes, are propelling Drug Delivery Systems market. Intrauterine Implants, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Prodrug Implants segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Drug Delivery Systems, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Drug Delivery Systems market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Drug Delivery Systems market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Drug Delivery Systems sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Drug Delivery Systems covered in this report include Novartis, Amgen, Roche, Pfizer, Johnson & Johnson, Becton Dickinson, AstraZeneca, Baxter and Bayer, etc.
The global Drug Delivery Systems market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • Novartis
  • Amgen
  • Roche
  • Pfizer
  • Johnson & Johnson
  • Becton Dickinson
  • AstraZeneca
  • Baxter
  • Bayer
  • Boston Scientific

Global Drug Delivery Systems market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Drug Delivery Systems market, Segment by Type:

  • Intrauterine Implants
  • Prodrug Implants
  • Polymeric Drug Delivery
  • Targeted Drug Delivery
  • Others

Global Drug Delivery Systems market, by Application

  • Cardiovascular Diseases
  • Oncology
  • Urology
  • Diabetes
  • CNS
  • Ophthalmology
  • Infections
  • Other

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Drug Delivery Systems companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Drug Delivery Systems
1.1 Drug Delivery Systems Market Overview
1.1.1 Drug Delivery Systems Product Scope
1.1.2 Drug Delivery Systems Market Status and Outlook
1.2 Global Drug Delivery Systems Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Drug Delivery Systems Market Size by Region (2018-2029)
1.4 Global Drug Delivery Systems Historic Market Size by Region (2018-2023)
1.5 Global Drug Delivery Systems Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Drug Delivery Systems Market Size (2018-2029)
1.6.1 North America Drug Delivery Systems Market Size (2018-2029)
1.6.2 Europe Drug Delivery Systems Market Size (2018-2029)
1.6.3 Asia-Pacific Drug Delivery Systems Market Size (2018-2029)
1.6.4 Latin America Drug Delivery Systems Market Size (2018-2029)
1.6.5 Middle East & Africa Drug Delivery Systems Market Size (2018-2029)
2 Drug Delivery Systems Market by Type
2.1 Introduction
2.1.1 Intrauterine Implants
2.1.2 Prodrug Implants
2.1.3 Polymeric Drug Delivery
2.1.4 Targeted Drug Delivery
2.1.5 Others
2.2 Global Drug Delivery Systems Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Drug Delivery Systems Historic Market Size by Type (2018-2023)
2.2.2 Global Drug Delivery Systems Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Drug Delivery Systems Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Drug Delivery Systems Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Drug Delivery Systems Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Drug Delivery Systems Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Drug Delivery Systems Revenue Breakdown by Type (2018-2029)
3 Drug Delivery Systems Market Overview by Application
3.1 Introduction
3.1.1 Cardiovascular Diseases
3.1.2 Oncology
3.1.3 Urology
3.1.4 Diabetes
3.1.5 CNS
3.1.6 Ophthalmology
3.1.7 Infections
3.1.8 Other
3.2 Global Drug Delivery Systems Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Drug Delivery Systems Historic Market Size by Application (2018-2023)
3.2.2 Global Drug Delivery Systems Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Drug Delivery Systems Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Drug Delivery Systems Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Drug Delivery Systems Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Drug Delivery Systems Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Drug Delivery Systems Revenue Breakdown by Application (2018-2029)
4 Drug Delivery Systems Competition Analysis by Players
4.1 Global Drug Delivery Systems Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug Delivery Systems as of 2022)
4.3 Date of Key Players Enter into Drug Delivery Systems Market
4.4 Global Top Players Drug Delivery Systems Headquarters and Area Served
4.5 Key Players Drug Delivery Systems Product Solution and Service
4.6 Competitive Status
4.6.1 Drug Delivery Systems Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Novartis
5.1.1 Novartis Profile
5.1.2 Novartis Main Business
5.1.3 Novartis Drug Delivery Systems Products, Services and Solutions
5.1.4 Novartis Drug Delivery Systems Revenue (US$ Million) & (2018-2023)
5.1.5 Novartis Recent Developments
5.2 Amgen
5.2.1 Amgen Profile
5.2.2 Amgen Main Business
5.2.3 Amgen Drug Delivery Systems Products, Services and Solutions
5.2.4 Amgen Drug Delivery Systems Revenue (US$ Million) & (2018-2023)
5.2.5 Amgen Recent Developments
5.3 Roche
5.3.1 Roche Profile
5.3.2 Roche Main Business
5.3.3 Roche Drug Delivery Systems Products, Services and Solutions
5.3.4 Roche Drug Delivery Systems Revenue (US$ Million) & (2018-2023)
5.3.5 Pfizer Recent Developments
5.4 Pfizer
5.4.1 Pfizer Profile
5.4.2 Pfizer Main Business
5.4.3 Pfizer Drug Delivery Systems Products, Services and Solutions
5.4.4 Pfizer Drug Delivery Systems Revenue (US$ Million) & (2018-2023)
5.4.5 Pfizer Recent Developments
5.5 Johnson & Johnson
5.5.1 Johnson & Johnson Profile
5.5.2 Johnson & Johnson Main Business
5.5.3 Johnson & Johnson Drug Delivery Systems Products, Services and Solutions
5.5.4 Johnson & Johnson Drug Delivery Systems Revenue (US$ Million) & (2018-2023)
5.5.5 Johnson & Johnson Recent Developments
5.6 Becton Dickinson
5.6.1 Becton Dickinson Profile
5.6.2 Becton Dickinson Main Business
5.6.3 Becton Dickinson Drug Delivery Systems Products, Services and Solutions
5.6.4 Becton Dickinson Drug Delivery Systems Revenue (US$ Million) & (2018-2023)
5.6.5 Becton Dickinson Recent Developments
5.7 AstraZeneca
5.7.1 AstraZeneca Profile
5.7.2 AstraZeneca Main Business
5.7.3 AstraZeneca Drug Delivery Systems Products, Services and Solutions
5.7.4 AstraZeneca Drug Delivery Systems Revenue (US$ Million) & (2018-2023)
5.7.5 AstraZeneca Recent Developments
5.8 Baxter
5.8.1 Baxter Profile
5.8.2 Baxter Main Business
5.8.3 Baxter Drug Delivery Systems Products, Services and Solutions
5.8.4 Baxter Drug Delivery Systems Revenue (US$ Million) & (2018-2023)
5.8.5 Baxter Recent Developments
5.9 Bayer
5.9.1 Bayer Profile
5.9.2 Bayer Main Business
5.9.3 Bayer Drug Delivery Systems Products, Services and Solutions
5.9.4 Bayer Drug Delivery Systems Revenue (US$ Million) & (2018-2023)
5.9.5 Bayer Recent Developments
5.10 Boston Scientific
5.10.1 Boston Scientific Profile
5.10.2 Boston Scientific Main Business
5.10.3 Boston Scientific Drug Delivery Systems Products, Services and Solutions
5.10.4 Boston Scientific Drug Delivery Systems Revenue (US$ Million) & (2018-2023)
5.10.5 Boston Scientific Recent Developments
6 North America
6.1 North America Drug Delivery Systems Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Drug Delivery Systems Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Drug Delivery Systems Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Drug Delivery Systems Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Drug Delivery Systems Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Drug Delivery Systems Market Dynamics
11.1 Drug Delivery Systems Industry Trends
11.2 Drug Delivery Systems Market Drivers
11.3 Drug Delivery Systems Market Challenges
11.4 Drug Delivery Systems Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock